{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:07:37Z","timestamp":1792188457442,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s10815-020-01745-2","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T21:02:51Z","timestamp":1585083771000},"page":"1037-1055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Navigating the body of literature assessing BRCA1\/2 mutations and markers of ovarian function: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"37","author":[{"given":"Christina N.","family":"Cordeiro Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey","family":"McGuinness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy S.","family":"Christianson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Segars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"1745_CR1","unstructured":"Breastcancer.org. U.S. Breast Cancer Statistics Ardmore, PA2018 [Available from: http:\/\/www.breastcancer.org\/symptoms\/understand_bc\/statistics."},{"issue":"2","key":"1745_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/ng1096-188","volume":"14","author":"C Oddoux","year":"1996","unstructured":"Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet. 1996;14(2):188\u201390.","journal-title":"Nat Genet"},{"issue":"12","key":"1745_CR3","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.2078.13.12","volume":"13","author":"AS Whittemore","year":"2004","unstructured":"Whittemore AS, Gong G, John EM, McGuire V, Li FP, Ostrow KL, et al. Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites. Cancer Epidemiol Biomark Prev. 2004;13(12):2078\u201383.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"23","key":"1745_CR4","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/jnci\/djj465","volume":"98","author":"HA Risch","year":"2006","unstructured":"Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 2006;98(23):1694\u2013706.","journal-title":"J Natl Cancer Inst"},{"key":"1745_CR5","doi-asserted-by":"publisher","first-page":"8297","DOI":"10.1158\/0008-5472.CAN-06-0503","volume":"66","author":"KE Malone","year":"2006","unstructured":"Malone KE, Daling JR, Doody DR, Hsu L, Bernstein L, Coates RJ, et al. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in White and Black American women ages 35 to 64 years. Cancer Res. 2006;66:8297\u2013308.","journal-title":"Cancer Res"},{"issue":"5","key":"1745_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00404-016-4187-6","volume":"294","author":"BD de la Noval","year":"2016","unstructured":"de la Noval BD. Potential implications on female fertility and reproductive lifespan in BRCA germline mutation women. Arch Gynecol Obstet. 2016;294(5):1099\u2013103.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"1745_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","volume":"28","author":"K Oktay","year":"2010","unstructured":"Oktay K, Kim JY, Barad D, Babayev SN. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks. J Clin Oncol. 2010;28(2):240\u20134.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1745_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/jama.290.7.929","volume":"290","author":"M de la Hoya","year":"2003","unstructured":"de la Hoya M, Fernandez JM, Tosar A, Godino J, Sanchez de Abajo A, Vidart JA, et al. Association between BRCA1 mutations and ratio of female to male births in offspring of families with breast cancer, ovarian cancer, or both. Jama. 2003;290(7):929\u201331.","journal-title":"Jama."},{"issue":"6811","key":"1745_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/35044000","volume":"408","author":"R Scully","year":"2000","unstructured":"Scully R, Livingston DM. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature. 2000;408(6811):429\u201332.","journal-title":"Nature."},{"issue":"52","key":"1745_CR10","doi-asserted-by":"publisher","first-page":"36083","DOI":"10.1074\/jbc.M109.025825","volume":"284","author":"RD Ballal","year":"2009","unstructured":"Ballal RD, Saha T, Fan S, Haddad BR, Rosen EM. BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage. J Biol Chem. 2009;284(52):36083\u201398.","journal-title":"J Biol Chem"},{"issue":"3","key":"1745_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/gcc.20290","volume":"45","author":"JD French","year":"2006","unstructured":"French JD, Dunn J, Smart CE, Manning N, Brown MA. Disruption of BRCA1 function results in telomere lengthening and increased anaphase bridge formation in immortalized cell lines. Genes Chromosom Cancer. 2006;45(3):277\u201389.","journal-title":"Genes Chromosom Cancer"},{"issue":"6","key":"1745_CR12","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/hmg\/ddl002","volume":"15","author":"JP McPherson","year":"2006","unstructured":"McPherson JP, Hande MP, Poonepalli A, Lemmers B, Zablocki E, Migon E, et al. A role for Brca1 in chromosome end maintenance. Hum Mol Genet. 2006;15(6):831\u20138.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"1745_CR13","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.fertnstert.2013.01.109","volume":"99","author":"A Finch","year":"2013","unstructured":"Finch A, Valentini A, Greenblatt E, Lynch HT, Ghadirian P, Armel S, et al. Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation. Fertil Steril. 2013;99(6):1724\u20138.","journal-title":"Fertil Steril"},{"issue":"4","key":"1745_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/jayao.2016.0009","volume":"5","author":"S Giordano","year":"2016","unstructured":"Giordano S, Garrett-Mayer E, Mittal N, Smith K, Shulman L, Passaglia C, et al. Association of BRCA1 mutations with impaired ovarian reserve: connection between infertility and breast\/ovarian cancer risk. J Adolesc Young Adult Oncol. 2016;5(4):337\u201343.","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"5","key":"1745_CR15","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.fertnstert.2017.03.018","volume":"107","author":"L Johnson","year":"2017","unstructured":"Johnson L, Sammel MD, Domchek S, Schanne A, Prewitt M, Gracia C. Antimullerian hormone levels are lower in BRCA2 mutation carriers. Fertil Steril. 2017;107(5):1256\u201365.e6.","journal-title":"Fertil Steril"},{"issue":"9","key":"1745_CR16","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/cncr.27952","volume":"119","author":"WT Lin","year":"2013","unstructured":"Lin WT, Beattie M, Chen LM, Oktay K, Crawford SL, Gold EB, et al. Comparison of age at natural menopause in BRCA1\/2 mutation carriers with a non-clinic-based sample of women in northern California. Cancer. 2013;119(9):1652\u20139.","journal-title":"Cancer."},{"issue":"1","key":"1745_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10549-006-9220-1","volume":"100","author":"I Rzepka-Gorska","year":"2006","unstructured":"Rzepka-Gorska I, Tarnowski B, Chudecka-Glaz A, Gorski B, Zielinska D, Toloczko-Grabarek A. Premature menopause in patients with BRCA1 gene mutation. Breast Cancer Res Treat. 2006;100(1):59\u201363.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1745_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.fertnstert.2017.12.009","volume":"109","author":"JM Hotaling","year":"2018","unstructured":"Hotaling JM, Laufer N, Rosenwaks Z. Introduction: cancer biomarkers and fertility. Fertil Steril. 2018;109(1):4\u20135.","journal-title":"Fertil Steril"},{"key":"1745_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.maturitas.2017.11.014","volume":"109","author":"A Podfigurna","year":"2018","unstructured":"Podfigurna A, Lukaszuk K, Czyzyk A, Kunicki M, Maciejewska-Jeske M, Jakiel G, et al. Testing ovarian reserve in pre-menopausal women: why, whom and how? Maturitas. 2018;109:112\u20137.","journal-title":"Maturitas."},{"issue":"1","key":"1745_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jogoh.2018.10.015","volume":"48","author":"M Victoria","year":"2019","unstructured":"Victoria M, Labrosse J, Krief F, Cedrin-Durnerin I, Comtet M, Grynberg M. Anti Mullerian hormone: more than a biomarker of female reproductive function. J Gynecol Obstet Hum Reprod. 2019;48(1):19\u201324.","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"1745_CR21","doi-asserted-by":"crossref","unstructured":"Derks-Smeets IAP, van Tilborg TC, van Montfoort A, Smits L, Torrance HL, Meijer-Hoogeveen M, et al. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF\/PGD. J Assist Reprod Genet. 2017.","DOI":"10.1007\/s10815-017-1014-3"},{"issue":"6","key":"1745_CR22","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.fertnstert.2014.08.014","volume":"102","author":"ET Wang","year":"2014","unstructured":"Wang ET, Pisarska MD, Bresee C, Chen YD, Lester J, Afshar Y, et al. BRCA1 germline mutations may be associated with reduced ovarian reserve. Fertil Steril. 2014;102(6):1723\u20138.","journal-title":"Fertil Steril"},{"issue":"10","key":"1745_CR23","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1210\/jc.2017-00765","volume":"102","author":"W Lin","year":"2017","unstructured":"Lin W, Titus S, Moy F, Ginsburg ES, Oktay K. Ovarian aging in women with BRCA germline mutations. J Clin Endocrinol Metab. 2017;102(10):3839\u201347.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1745_CR24","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/humrep\/dew044","volume":"31","author":"K-A Phillips","year":"2016","unstructured":"Phillips K-A, Collins IM, Milne RL, McLachlan SA, Friedlander M, Hickey M, et al. Anti-M\u00fcllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations. Hum Reprod. 2016;31(5):1126\u201332.","journal-title":"Hum Reprod"},{"issue":"172","key":"1745_CR25","doi-asserted-by":"publisher","first-page":"172ra21","DOI":"10.1126\/scitranslmed.3004925","volume":"5","author":"S Titus","year":"2013","unstructured":"Titus S, Li F, Stobezki R, Akula K, Unsal E, Jeong K, et al. Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans. Sci Transl Med. 2013;5(172):172ra21.","journal-title":"Sci Transl Med"},{"key":"1745_CR26","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3389\/fendo.2018.00772","volume":"9","author":"YS Choi","year":"2018","unstructured":"Choi YS, Park JH, Lee JH, Yoon JK, Yun BH, Park JH, et al. Association between impairment of DNA double strand break repair and decreased ovarian reserve in patients with endometriosis. Front Endocrinol. 2018;9:772.","journal-title":"Front Endocrinol"},{"issue":"1","key":"1745_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1933719117728800","volume":"25","author":"V Turan","year":"2018","unstructured":"Turan V, Bedoschi G, Emirdar V, Moy F, Oktay K. Ovarian stimulation in patients with cancer: impact of letrozole and BRCA mutations on fertility preservation cycle outcomes. Reprod Sci. 2018;25(1):26\u201332.","journal-title":"Reprod Sci"},{"issue":"2","key":"1745_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.fertnstert.2018.10.014","volume":"111","author":"V Gunnala","year":"2019","unstructured":"Gunnala V, Fields J, Irani M, D\u2019Angelo D, Xu K, Schattman G, et al. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation. Fertil Steril. 2019;111(2):363\u201371.","journal-title":"Fertil Steril"},{"issue":"2","key":"1745_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/IGC.0000000000000058","volume":"24","author":"R Michaelson-Cohen","year":"2014","unstructured":"Michaelson-Cohen R, Mor P, Srebnik N, Beller U, Levy-Lahad E, Eldar-Geva T. BRCA mutation carriers do not have compromised ovarian reserve. Int J Gynecol Cancer. 2014;24(2):233\u20137.","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"1745_CR30","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1093\/humrep\/dew242","volume":"31","author":"TC van Tilborg","year":"2016","unstructured":"van Tilborg TC, Derks-Smeets IA, Bos AM, Oosterwijk JC, van Golde RJ, de Die-Smulders CE, et al. Serum AMH levels in healthy women from BRCA1\/2 mutated families: are they reduced? Hum Reprod. 2016;31(11):2651\u20139.","journal-title":"Hum Reprod"},{"issue":"1","key":"1745_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/annonc\/mdx639","volume":"29","author":"M Lambertini","year":"2018","unstructured":"Lambertini M, Goldrat O, Ferreira AR, Dechene J, Azim HA Jr, Desir J, et al. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients. Ann Oncol. 2018;29(1):237\u201343.","journal-title":"Ann Oncol"},{"issue":"5","key":"1745_CR32","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.fertnstert.2015.07.1162","volume":"104","author":"M Shapira","year":"2015","unstructured":"Shapira M, Raanani H, Feldman B, Srebnik N, Dereck-Haim S, Manela D, et al. BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles. Fertil Steril. 2015;104(5):1162\u20137.","journal-title":"Fertil Steril"},{"issue":"5","key":"1745_CR33","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/1933719113506498","volume":"21","author":"ME Pavone","year":"2014","unstructured":"Pavone ME, Hirshfeld-Cytron J, Tingen C, Thomas C, Thomas J, Lowe MP, et al. Human ovarian tissue cortex surrounding benign and malignant lesions. Reprod Sci. 2014;21(5):582\u20139.","journal-title":"Reprod Sci"},{"key":"1745_CR34","unstructured":"The_Nordic_Cochrane_Centre. Review Manager (RevMan). Version 5.3 ed. Copenhagen: The Cochrane Collaboration; 2014."},{"key":"1745_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"issue":"7414","key":"1745_CR36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003;327(7414):557\u201360.","journal-title":"Bmj."},{"issue":"3","key":"1745_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1095\/biolreprod.115.132290","volume":"93","author":"K Oktay","year":"2015","unstructured":"Oktay K, Turan V, Titus S, Stobezki R, Liu L. BRCA mutations, DNA repair deficiency, and ovarian aging. Biol Reprod. 2015;93(3):67.","journal-title":"Biol Reprod"},{"issue":"12","key":"1745_CR38","doi-asserted-by":"publisher","first-page":"e1007752","DOI":"10.1371\/journal.pgen.1007752","volume":"14","author":"MS Cline","year":"2018","unstructured":"Cline MS, Liao RG, Parsons MT, Paten B, Alquaddoomi F, Antoniou A, et al. BRCA challenge: BRCA exchange as a global resource for variants in BRCA1 and BRCA2. PLoS Genet. 2018;14(12):e1007752.","journal-title":"PLoS Genet"},{"issue":"1","key":"1745_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10549-018-4887-7","volume":"172","author":"I Barnes-Kedar","year":"2018","unstructured":"Barnes-Kedar I, Bernstein-Molho R, Ginzach N, Hartmajer S, Shapira T, Magal N, et al. The yield of full BRCA1\/2 genotyping in Israeli high-risk breast\/ovarian cancer patients who do not carry the predominant mutations. Breast Cancer Res Treat. 2018;172(1):151\u20137.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-020-01745-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-020-01745-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-020-01745-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T13:57:27Z","timestamp":1666187847000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-020-01745-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1745"],"URL":"https:\/\/doi.org\/10.1007\/s10815-020-01745-2","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]},"assertion":[{"value":"16 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}